Stay updated on ALLO-715 BCMA CAR T Safety/Efficacy in MM Clinical Trial
Sign up to get notified when there's something new on the ALLO-715 BCMA CAR T Safety/Efficacy in MM Clinical Trial page.

Latest updates to the ALLO-715 BCMA CAR T Safety/Efficacy in MM Clinical Trial page
- Check6 days agoChange DetectedA consolidated Locations section was added listing sites in AZ, CA, CO, MN, NY, OH, TN, TX, and WI, and per-state location headings were removed. The page revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study, and added revision: v3.3.2.SummaryDifference0.1%

- Check41 days agoChange DetectedA notice regarding government funding and NIH operating status was removed from the page.SummaryDifference0.4%

- Check56 days agoChange DetectedCore study details including status, enrollment, eligibility criteria, locations, and primary outcomes appear unchanged; the changes observed seem to be cosmetic/UI adjustments only. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a prominent government funding notice and a current operating status note, plus a version update to v3.2.0; removed the previous v3.1.0 revision tag.SummaryDifference4%

- Check92 days agoChange DetectedUpdated the disease name from Plasma cell myeloma to Multiple myeloma and incremented the revision to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to ALLO-715 BCMA CAR T Safety/Efficacy in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLO-715 BCMA CAR T Safety/Efficacy in MM Clinical Trial page.